Hypermethylation of CCNA1 and TIMP3 might be a promising genetic marker to predict the incidence of SPT in HNSCC subjects, providing the basis for the use of preventive measures and adjuvant treatment. This evidence concerns the gene CCNA1 and head and neck squamous cell carcinoma.